Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance

about

Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance

Item

http://www.wikidata.org/entity/Q57167969

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Future prospects of immune che ...... ction to overcoming resistance

@en

Future prospects of immune che ...... ction to overcoming resistance

@nl

type

Item

label

Future prospects of immune che ...... ction to overcoming resistance

@en

Future prospects of immune che ...... ction to overcoming resistance

@nl

prefLabel

Future prospects of immune che ...... ction to overcoming resistance

@en

Future prospects of immune che ...... ction to overcoming resistance

@nl

P1476

Future prospects of immune che ...... ction to overcoming resistance

@en

P2093

Da-Sol Kuen

http://www.w3.org/2001/XMLSchema#string

Young-Jun Park

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function

The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data

Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis

Evolutionary determinants of cancer

Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications

Nivolumab plus ipilimumab in advanced melanoma.

P2888

s12276-018-0130-1

P304

109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1038/S12276-018-0130-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yeonseok Chung

P577

2018-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30135516

http://www.w3.org/2001/XMLSchema#string

P921

molecular medicine

molecular biology

P932

6105674

http://www.w3.org/2001/XMLSchema#string